Chronic kidney disease trials recruiting in Iowa

All Chronic kidney disease trials nationally

Cities in Iowa

Recruiting trials in Iowa

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Iowa City, West Des Moines
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Iowa: Iowa City
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Ames
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · Iowa: Iowa City
• CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
  NCT05931276 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Iowa City
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Iowa: Ames, Ankeny, Boone, Cedar Rapids
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Sioux City
• Empagliflozin Treatment in Kidney Transplant Recipients
  NCT06013865 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · Iowa: Iowa City
• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
  NCT06858319 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Iowa: Iowa City
• Patient-driven Management of BP in CKD
  NCT05546099 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Iowa City